Carna Health Raises $8 Million to Scale AI-Driven Chronic Kidney Disease Screening Platform Globally
核心洞察
Carna Health (搜索) secured $8 million in funding to expand global access to its AI-enabled chronic kidney disease screening and care management technology platform.
The Boston-based digital health company recently partnered with Siemens Healthineers (搜索) to scale preventive kidney care worldwide, completing an initiative in Cameroon that enrolled 35,000 individuals.
The company plans to launch multiple programs in the Philippines and develop a national initiative in the Dominican Republic, while also expanding into the United States and Turkey.
Carna Health (搜索), a Boston-based digital health company, announced it has raised $8 million to expand global access to its chronic kidney disease screening and care management technology. The funding round included participation from Dr. Jay Rosan, Cenk Bekmezçi, Jose Pereyra, Mark Boulding, Brandon Salomon, Andrew Roosevelt, Jeff Lindsey, Joseph White, John Brooks, Elvis Ndansi and Dr. Salvatore Viscomi.
The capital raise follows Carna Health (搜索)'s recent strategic partnership with Siemens Healthineers (搜索) aimed at scaling preventive kidney care worldwide. By combining Carna Health's digital platform with Siemens Healthineers' global point-of-care diagnostics infrastructure, the partnership seeks to broaden access to kidney screening and follow-up care.
AI-Driven Platform for Early Detection
Carna Health (搜索) will use the funding to accelerate innovation and growth for its AI-enabled platform focused on early identification, monitoring and patient management for chronic kidney disease (CKD). The company's digital health platform integrates artificial intelligence-driven solutions to help patients and healthcare providers navigate care pathways more effectively.
"This funding enables us to continue global expansion, offering a transformative digital health platform that expands access to comprehensive chronic kidney disease (CKD) care," said Salvatore Viscomi, MD, Chief Executive Officer of Carna Health (搜索). "By integrating AI-driven solutions for early identification, monitoring, and patient management, we're empowering patients and healthcare providers to navigate care pathways more effectively."
Proven Results in Large-Scale Screening
The company recently completed an initiative in Cameroon with Siemens Healthineers (搜索) and NeoDocs (搜索) that enrolled 35,000 individuals across the Southwest and Littoral regions. Data from Carna Health (搜索)'s screening programs suggests that large-scale, cost-effective approaches can identify previously undiagnosed disease and create opportunities for earlier intervention.
"Chronic diseases present significant challenges, including late diagnoses and inadequate management," said Dr. Jay Rosan, an investor in the round. "This funding will enable us to accelerate Carna Health (搜索)'s mission to provide effective, accessible tools that empower both patients and healthcare clinicians to tackle these challenges head-on. Our goal is to show that Carna Health's platform can be seamlessly implemented worldwide and integrated with any health system, ensuring we reach as many people as possible."
Global Expansion Plans
Carna Health (搜索) plans to launch multiple programs in the Philippines in partnership with major cities and leading healthcare systems. The company also has a national initiative under development in the Dominican Republic and intends to expand into the United States and Turkey.
"Reliable distribution and operational readiness are fundamental to the success of population health programs," said Cenk Bekmezçi, an investor. "Carna Health (搜索) has developed a robust platform that functions effectively across diverse markets and infrastructure levels. Reaching this funding milestone enables a more coordinated, scalable approach to chronic disease management. We are pleased to partner with Carna Health to introduce this innovative solution to the Turkish market."
Industry Recognition
Carna Health (搜索) has received international recognition for its work in kidney health innovation, including selection for a United Nations-supported AI for Good publication, inclusion in the textbook "Innovations in Nephrology: Breakthrough Technologies in Kidney Disease Care," and recognition as a finalist in the Fierce Life Sciences Innovation Awards.
Founded in 2021, Carna Health (搜索) focuses on transforming Cardio-Kidney-Metabolic care with chronic kidney disease as its first indication. The company's mission is to slow the global progression of CKD and related metabolic conditions through its integrated point-of-care testing solutions and AI-driven software platform.